pharmaceutical investing Corbus Pharmaceuticals to Commence Phase 3 Study of Lenabasum for the Treatment of Rare Autoimmune Disease Dermatomyositis
pharmaceutical investing Corbus Pharmaceuticals Receives FDA Orphan Drug Designation for Lenabasum for the Treatment of Dermatomyositis
Lahontan Plans Drilling to Test Historic Waste Rock at Santa Fe - A Potential Source of Additional Low Cost Gold Production
Nevada Sunrise Completes Ground Gravity Survey at the Fivemile Gold Project, Cortez Mining District, Nevada
CoTec Holdings Corp. Notes HyProMag USA Advances North Texas Rare Earth Magnet Facility With First Major Equipment Delivery
